A vs RNXT · P/E 29, rev $1.88B vs rev $266.0K
Agilent Technologies Inc (A) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
A currently screens at market cap $33.70B and trailing P/E 29.2. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the A and RNXT stock pages for the full models.
Not investment advice.